Neogenomics (NEO) Depreciation and Depletion (2010 - 2026)

Neogenomics (NEO) has reported Depreciation and Depletion for 17 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $8.8 million, down 6.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.5 million (down 7.98% YoY), and the FY2025 annual result was $36.1 million, down 7.75% from the prior year.
• Depreciation and Depletion was $8.8 million for Q1 2026 at Neogenomics, roughly flat from $8.8 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $9.9 million in Q1 2024 and troughed at $8.4 million in Q1 2022.
• Average Depreciation and Depletion over 5 years is $9.2 million, with a median of $9.3 million recorded in 2023.
• Year-over-year, Depreciation and Depletion grew 25.67% in 2022 and slipped 10.83% in 2025.
• Over 5 years, Depreciation and Depletion stood at $9.5 million in 2022, then gained by 1.06% to $9.6 million in 2023, then increased by 2.6% to $9.8 million in 2024, then retreated by 10.83% to $8.8 million in 2025, then rose by 0.19% to $8.8 million in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $8.8 million in Q1 2026, $8.8 million in Q4 2025, and $8.8 million in Q3 2025.